Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer

Gene replacement therapy is an attractive approach for treatment of genetic disease, but may be complicated by the risk of a neutralizing immune response to the therapeutic gene product. There are examples of humoral and cellular immune responses against the transgene product as well as absence of s...

Descrición completa

Detalles Bibliográficos

Publicado en:	J Clin Invest
Principais autores:	Mingozzi, Federico, Liu, Yi-Lin, Dobrzynski, Eric, Kaufhold, Antje, Liu, Jian Hua, Wang, YuQin, Arruda, Valder R., High, Katherine A., Herzog, Roland W.
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Clinical Investigation 2003
Assuntos:	Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC154443/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12727926/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI16887
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!